Consolidating the Role of TDP2 Mutations in Recessive Spinocerebellar Ataxia Associated with Pediatric Onset Drug Resistant Epilepsy and Intellectual Disability (SCAR23)

Cerebellum. 2019 Oct;18(5):972-975. doi: 10.1007/s12311-019-01069-7.

Abstract

Spinocerebellar Ataxia 23 (SCAR23) is a newly described condition caused by mutations in TDP2 gene. To date, only four patients from two families have been reported, all carrying the same homozygous mutation. We describe a fifth patient, carrying a novel mutation in the same gene, thus confirming the role of TDP2 mutations in determining the disease and defining the main features SCAR23: pediatric onset ataxia and drug-resistant epilepsy and intellectual disability. We further show the clinical presentation which is associated with the neuroradiological evidence of progressive cerebellar atrophy, giving the evidence that SCAR23 can be classified as a degenerative condition.

Keywords: Cerebellar atrophy; Pediatric ataxia; SCAR23; Spinocerebellar ataxia; TDP2.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • DNA-Binding Proteins / genetics*
  • Drug Resistant Epilepsy / complications
  • Drug Resistant Epilepsy / diagnostic imaging
  • Drug Resistant Epilepsy / genetics*
  • Exome Sequencing / methods
  • Female
  • Humans
  • Intellectual Disability / complications
  • Intellectual Disability / diagnostic imaging
  • Intellectual Disability / genetics*
  • Mutation / genetics*
  • Phosphoric Diester Hydrolases / genetics*
  • Spinocerebellar Ataxias / complications
  • Spinocerebellar Ataxias / diagnostic imaging
  • Spinocerebellar Ataxias / genetics*

Substances

  • DNA-Binding Proteins
  • Phosphoric Diester Hydrolases
  • TDP2 protein, human